Podcast: Play in new window | Download | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | RSS
Myopia management, also known as myopia control, has rapidly evolved from a niche specialty into one of the most important areas of modern pediatric eye care. Yet despite advances in research and treatment, misconceptions continue to influence conversations between doctors and families.
Many parents still believe worsening nearsightedness is simply inherited, while some clinicians remain uncertain about axial length monitoring, spectacle therapies, and lifestyle recommendations. As childhood myopia rates continue to rise worldwide, separating fact from fiction has never been more important.
In Partnership with CooperVision
In this Defocus Media MythBusters episode, Dr. Jennifer Lyerly welcomes Dr. Justin Kwan, Head of Myopia Management at CooperVision, to tackle the most common myths surrounding childhood myopia and provide evidence-based strategies every optometrist can use in clinical practice.
Table of Contents
What Is Myopia Management?
Myopia management, or myopia control, refers to evidence-based treatments designed to slow childhood myopia progression by reducing excessive axial elongation and lowering the lifetime risk of retinal detachment, glaucoma, cataracts, and myopic maculopathy associated with high myopia.
Rather than simply prescribing stronger glasses every year, modern myopia management focuses on preserving lifelong ocular health through early intervention.
Myth #1: “Myopia is Just Genetics”
Perhaps the most common misconception parents express is that childhood myopia is inevitable because one or both parents are nearsighted.
While genetics certainly influence risk, current research suggests environmental factors—including outdoor activity, near work, and visual behaviors—play a substantial role in myopia development and progression.
Rather than accepting worsening vision as unavoidable, clinicians now have evidence-based opportunities to intervene early and influence long-term outcomes through proactive myopia management. Genetics may increase risk, but they do not eliminate opportunity.
Myth #2: “Screens and Video Games Are Causing Myopia”
Parents frequently ask whether phones, tablets, or video games are responsible for their child’s worsening prescription.
Although prolonged screen use deserves attention, evidence suggests that increasing outdoor time may provide greater protective benefit than simply reducing screen time alone.
The message for families should focus less on punishment and more on replacement. Encouraging children to spend additional time outdoors while balancing healthy visual habits may provide greater benefit than simply limiting electronic devices.
Sometimes the best prescription isn’t fewer screens—it’s more sunshine.
Myth #3: “The Prescription Changed, So Myopia Control Isn’t Working”
One of the biggest challenges in myopia management is setting expectations.
Parents often expect treatment to completely stop prescription changes. However, evidence-based myopia control therapies are designed to slow progression, not eliminate progression entirely.
Current studies demonstrate approximately 50–60% reduction in myopia progression with many available treatment options compared with traditional correction alone. A child whose prescription continues to change slowly during treatment may still be experiencing excellent clinical success.
Managing expectations from the very first visit often leads to better long-term treatment adherence and greater parent confidence.
Myth #4: “Can’t My Child Just Get LASIK Later?”
LASIK corrects refractive error. It does not shorten an elongated eye. Even after refractive surgery, patients with high myopia continue to carry elevated risks for retinal detachment, glaucoma, cataracts, and myopic retinal degeneration because axial elongation remains unchanged.
Myopia management focuses on preventing excessive eye growth during childhood before those structural risks become permanent. This is why early intervention matters.
Myth #5: “My Child Is Too Young for Contact Lenses”
Many parents hesitate when contact lenses become part of the myopia management discussion.
Clinical experience demonstrates that appropriately selected elementary-aged children can successfully wear daily disposable contact lenses under proper supervision. Age alone should not determine candidacy.
Fortunately, today’s clinicians can individualize treatment using FDA-approved myopia-control contact lenses, such as MiSight® 1 day, specialty spectacle lenses, or pharmaceutical therapies, based on each child’s needs, risk profile, and family preferences.
Myth #6: “You Need Axial Length Measurements to Practice Myopia Management”
Among clinicians, this may be one of the most persistent misconceptions.
Axial length monitoring provides valuable information regarding structural eye growth, but it represents the research gold standard—not the current standard of care.
Optometrists should never delay evidence-based myopia management simply because advanced instrumentation is unavailable.
Clinical history, refractive progression, comprehensive examination findings, and risk assessment remain valuable tools for initiating treatment. The priority should always be treating children—not waiting for technology.
Myth #7: “Progressive or Anti-Fatigue Glasses Are Effective Myopia Control Treatments”
Historically, some clinicians attempted myopia control using progressive addition lenses or anti-fatigue spectacles.
While traditional progressive and anti-fatigue lenses may provide visual comfort benefits, newer myopia control spectacle lenses, such as Essilor Stellest® lenses, have been specifically designed to slow childhood myopia progression. These technologies, along with evidence-based contact lens options, provide clinicians with more effective tools for managing pediatric myopia than conventional single-vision or progressive lenses.
Clinicians should prioritize treatments supported by contemporary clinical evidence.
Myth #8: “Axial Length Always Changes Before Prescription Changes”
Another misconception involves the relationship between axial elongation and refractive progression.
While axial length monitoring provides valuable insight into structural growth, refractive change and axial elongation generally occur together once childhood myopia has developed.
Understanding this relationship helps clinicians communicate more effectively with families while avoiding unnecessary confusion regarding treatment success.
Myth #9: “The 20/20/20 Rule Prevents Myopia”
The 20/20/20 rule has become synonymous with reducing digital eye strain. However, its role in slowing childhood myopia progression remains limited.
Current evidence suggests that increasing outdoor activity and taking longer breaks from prolonged near work provide greater benefit than brief visual breaks alone. Lifestyle modification should complement—not replace—evidence-based myopia management.
Myth #10: “Apple Screen Distance Alerts Are Enough for Myopia Control”
Modern technology includes screen-distance notifications and screen-time reminders designed to encourage healthier visual habits. While these tools may reinforce healthy behaviors, they should not be viewed as primary therapies for myopia management. Behavioral modification works best when combined with proven optical interventions and increased outdoor activity.
Technology can support healthy habits, but it cannot replace evidence-based clinical care.
How Can Optometrists Explain Myopia Management to Parents?
One of the simplest explanations may also be the most effective.
When today’s parents were children, worsening prescriptions were accepted as normal because treatment options did not exist. Today, evidence-based myopia management provides clinicians with tools to slow progression and reduce long-term ocular health risks.
By shifting the conversation from stronger glasses to healthier eyes, optometrists help families understand that myopia control is an investment in lifelong vision rather than simply another prescription.
Where Can Doctors Learn More About Myopia Management?
Research surrounding childhood myopia continues to evolve rapidly.
Continuing education programs, peer-reviewed literature, national optometric meetings, and organizations dedicated to myopia management provide clinicians with valuable resources for answering patient questions and implementing evidence-based care.
As knowledge grows, so does the opportunity to improve outcomes for future generations.
Want to stay at the forefront of myopia management, myopia control, and the latest innovations in eye care? Subscribe to the Defocus Media Podcast Network for expert interviews, clinical insights, practice management strategies, and evidence-based conversations designed to help optometrists elevate patient care and grow their practices.
Join thousands of eye care professionals who turn to Defocus Media—Optometry’s #1 Podcast Network—for the latest education, innovation, and inspiration shaping the future of the profession.
